NCT04394507
- Conditions
- Cardiovascular Abnormalities, Cardiovascular Diseases, Congenital Abnormalities, +9 more
- Locations
-
- Aarhus University Hospital Aarhus N, Central Jutland, Denmark
- Aarhus University Aarhus C, Danmark, Denmark
Clinical trial condition
Lymphatic Diseases
Explore clinical trials studying Lymphatic Diseases. Study availability and eligibility vary by location and protocol.
9,012 public trials
1,844 recruiting studies
Lymphatic Diseases trial results
NCT03634462
- Conditions
- Connective Tissue Diseases, Hemic and Lymphatic Diseases, Lipedema, +4 more
- Locations
-
- Vanderbilt University Medical Center Nashville, Tennessee, United States
NCT03502876
- Conditions
- B Cell Chronic Lymphocytic Leukemia, Chronic Disease, Disease Attributes, +14 more
- Locations
-
- FILO French Innovative Leukemia Organization Tours, France
- Project manager Tours, France
Completed
Meloxicam vs Placebo for Mobilization
NCT02003625
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +19 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
Completed
Tumor Registry of Lymphatic Neoplasia
NCT00889798
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +31 more
- Locations
-
Not specified
Completed
Alisertib in Treating Young Patients With Recurrent or Refractory Solid Tumors or Leukemia
NCT01154816
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Hepatoblastoma, +33 more
- Locations
-
- Children's Hospital of Alabama Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Southern California Permanente Medical Group Downey, California, United States
NCT00066404
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +114 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
Completed
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies
NCT02223052
- Conditions
- Acute Myeloid Leukemia, Adenocarcinoma, Adnexal Diseases, +106 more
- Locations
-
- Scottsdale Healthcare Research Institute Scottsdale, Arizona, United States
- Mayo Clinic - Arizona Scottsdale, Arizona, United States
- University of Arizona Cancer Center Tucson, Arizona, United States
- University of Iowa Iowa City, Iowa, United States
NCT01081015
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
- Locations
-
- New Hope Cancer & Research Institute Pomona, California, United States
- Medical Specialists of the Palm Beaches Atlantis, Florida, United States
- University Cancer Institute Boynton Beach, Florida, United States
- Thomas Niederman, MD Boynton Beach, Florida, United States
Completed
Safety and Efficacy of Revlimid® (Lenalidomide) With Mabthera® (Rituximab) in Non-Hodgkin's Lymphoma
NCT01939327
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Institut Paoli-Calmettes Marseille, France